SOFT-TISSUE SARCOMA WITH ADDITIONAL ANAPLASTIC COMPONENTS - A CLINICOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY OF 27 CASES

被引:0
|
作者
HASHIMOTO, H
DAIMARU, Y
TSUNEYOSHI, M
ENJOJI, M
机构
[1] Second Department of Pathology, Faculty of Medicine, Kyushu University, Fukuoka
[2] Pathology Laboratory, Matsuyama Red Cross Hospital, Matsuyama, 790
关键词
D O I
10.1002/1097-0142(19901001)66:7<1578::AID-CNCR2820660724>3.0.CO;2-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This clinicopathologic study concerns 27 cases of “dedifferentiated” soft tissue sarcoma (DSTS), including 14 liposarcomas, six leiomyosarcomas, five chondrosarcomas, and two rhabdomyosarcomas. In addition, the authors conducted an immunohistochemical survey of 23 cases and an electron microscopic examination of three. The findings were compared with observations of 32 cases of de novo malignant fibrous histiocytoma (MFH). All tumors contained additional distinct anaplastic portions indistinguishable from MFH under conventional light microscopy, ultrastructurally, and in cases of immunoreactivity for alpha‐1‐antichymotrypsin and alpha‐1‐antitrypsin and on lectin histochemical findings for ricinus communis agglutinin and concanavalin agglutinin. The desmin reactivity present in anaplastic portions of 14 DSTS and in eight de novo MFH is taken to mean that myofibroblasts are present in these tumors. The anaplastic components of DSTS are presumed to represent the proliferation of another clone of undifferentiated mesenchymal cells that fail to differentiate along any specific lineage other than fibroblast‐like cells, histiocyte‐like cells, and myofibroblasts. Nineteen patients died of tumor and four are alive and well 1.6, 1.7, 2.1, and 5.2 years after the initial treatment, respectively. Copyright © 1990 American Cancer Society
引用
收藏
页码:1578 / 1589
页数:12
相关论文
共 50 条
  • [31] ALVEOLAR SOFT-TISSUE SARCOMA
    POROSHIN, KK
    KRYLOV, LM
    KUDRYAVTSEV, BN
    ARKHIV PATOLOGII, 1989, 51 (05) : 51 - 58
  • [32] REIRRADIATION OF SOFT-TISSUE SARCOMA
    GRAHAM, JD
    ROBINSON, MH
    HARMER, CL
    BRITISH JOURNAL OF RADIOLOGY, 1992, 65 (770): : 157 - 161
  • [33] AMPUTATIONS FOR SOFT-TISSUE SARCOMA
    WESTBURY, G
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 1991, 73 (03) : 163 - 164
  • [34] Eribulin in soft-tissue sarcoma
    Young, Robin J.
    Woll, Penella J.
    LANCET, 2016, 387 (10028): : 1594 - 1596
  • [35] Soft-tissue sarcoma - Reply
    Clark, MA
    Fisher, C
    Thomas, JM
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (21): : 2303 - 2304
  • [36] Soft-tissue sarcoma of the foot
    Latt, L. Daniel
    Turcotte, Robert E.
    Isler, Marc H.
    Wong, Cynthia
    CANADIAN JOURNAL OF SURGERY, 2010, 53 (06) : 424 - 431
  • [37] PROGNOSIS IN SOFT-TISSUE SARCOMA
    ROOSER, B
    ACTA ONCOLOGICA, 1988, 27 (04) : 419 - 419
  • [38] SOFT-TISSUE SARCOMA - REPLY
    SERRAINO, D
    FRANCESCHI, S
    LAVECCHIA, C
    CANCER CAUSES & CONTROL, 1992, 3 (05) : 494 - 494
  • [39] SOFT-TISSUE SARCOMA AND HYPERCALCEMIA
    VREUGDENHIL, G
    DEMULDER, PHM
    VANHOESEL, Q
    ANNALS OF ONCOLOGY, 1995, 6 (01) : 89 - 90
  • [40] Amputation for soft-tissue sarcoma
    Clark, MA
    Thomas, JM
    LANCET ONCOLOGY, 2003, 4 (06): : 335 - 342